I am sickened by Dr. Prasad insinuating that patient advocacy organizations work in the interest of Pharma. All stakeholders need to work together to attain the best possible outcomes for all patients. #mmsm

Congratulations to International Myeloma Foundation and collaborating team on this milestone!

Now we might need RP2D for getting the right dose( of all the chutneys)

But I am sure we don’t need any randomized trial to approve it !

Who agrees ??

#PaniPuri
#Bestfoodever

Sometimes we can’t wait for decades to watch 🌔 #SolarEclipse2024 !

Jk; pictures from our backyard ! (Also enjoy the video)

NASA Blue Moon Brewing Co SolBeerSA

Such a sad fate of healthcare 👇👇👇

I know ASH and ASCO are trying, we need urgent intervention. This is extortion. Please come out with strong statements urging this to be stopped ASAP.

And a New England Patriots fan here along with being a hematologist !

This is just an awesome 😎 day :) Happy 3-28 !

#MedTwitter
#NFL
Tom Brady
Bruce Levine, Ph.D. 🇺🇦

Tadaa.. I have Zero 0️⃣ email inbox !📥

Wishing Kate Middleton well on her cancer journey. It’s never easy, no matter what we say. I could just imagine what you and your family are going through. Sending positive vibes and thoughts your way 🙏

British Royal News The Prince and Princess of Wales

facebook.com/share/v/jQJC6u…

Is this real ? We have #AishwaryaRai picture on a steak 🥩 house billboard in Dallas ?

Gurbakhash Kaur Shaalan Beg MD MBA FASCO

Blood is red,
Veins can look blue.
All my heart wants,
Is NIH funding for you.

#HealthPolicyValentines

🚨 NEWS 🚨

Supplemental Biologics License Application submitted to U.S. FDA for a new indication of D-VRd, for induction/consolidation, and dara-lenalidomide, as maintenance therapy, in transplant-eligible NDMM; this is based on data from the phase III PERSEUS trial.

Read more:…

How can you not love ❤️ this guy !! I all kids (& adults) get amazing teacher like him :)

I am teaching my 3rd grader 🧒 and have to use this 4 sure !

Cc some other excellent 🧑‍🏫 Dr. Glaucomflecken David Steensma, MD Eric Topol

Challenging issue in #CARTcell therapy: hematological toxicity. A recent manuscript in Blood Advances discusses use of EHA/EBMT scoring on ICAHT to address this. More risk mitigation options may come from this scoring system.

Link: [shorturl.at/fovI7]

p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy from team at UCLA

Is there a role of small molecules in targeting this signaling pathway? 🧐

#MMsm

Link: mdpi.com/2072-6694/16/2…

Check out this superb article on chromosomal defects in multiple myeloma. It covers the use of FISH to SNP microarray. A must-read for all hematology-oncology fellows!

Link: [sciencedirect.com/science/articl…]

#MMsm #hematologyoncology ASH 😊

🚨NEW Commentary on #FDA 11/28/23 announcement 'Unanswered questions following reports of secondary malignancies after CAR-T cell therapy' Nature Medicine - A consensus commentary from @ISCTGlobal ASTCT The EBMT CIBMTR Parker Institute for Cancer Immunotherapy Marcelo Pasquini John Connolly David Porter…

Excited to share our review on MRD and decision-making in myeloma. We cover the latest in tech, incl. mass spec, and we delve into the case for MRD to guide decision-making. Was great to work with Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 on this! #mmsm #mmMRD
authors.elsevier.com/a/1iNkK3AL9d2v… (free link)

Busulfan, melphalan and carfilzomib high‐dose chemotherapy and autologous haematopoietic stem... - goo.gl/scholar/UT6Jp3 #ScholarAlerts

Interesting study exploring benefit of patient advocacy groups at Non Profit hospitals on patient outcomes
#MMsm
⁦The Leukemia & Lymphoma Society⁩ ⁦university of miami⁩ clinicaltrials.gov/study/NCT05745…